1. Volume 126, Issue 3, Pages 935-936 (March 2004)
Reply to Horiuchi 
Jan H.M. Van Den Brande, Henri Braat, Sander J.H. Van Deventer, Maikel P. Peppelenbosch 
Gastroenterology 
Volume 126, Issue 3, Pages (March 2004)
DOI: /j.gastro

2. Figure 1
Infliximab reduces Bad phosphorylation. (A) Using a phosphoSer136 Bad reactive antiserum (Cell Signaling Technology, Beverly, MA) and Western blotting the effects of infliximab on survival signaling were investigated in MLR-stimulated human T cells as previously described.1 (B) Quantification of chemiluminescence using imaging software.
Gastroenterology  , DOI: ( /j.gastro )